Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Medications for opioid use disorders among incarcerated persons and those in the community supervision setting: exploration of implementation issues with key stakeholders

Addiction Science & Clinical Practice(2024)10.1186/s13722-024-00528-9Source: DataRank Database

Medications for opioid use disorders among incarcerated persons and those in the community supervision setting: exploration of implementation issues with key stakeholders is a research paper published in Addiction Science & Clinical Practice (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.20)OA: goldTopics (62)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Amelia Bailey ORCID,Anthony Surace ORCID,L. A. R. Stein ORCID,Damaris J. Rohsenow ORCID,Rosemarie A. Martin ORCID

Live enrichment

PubMed:39696603 OpenAlex:https://openalex.org/W4405550522

NIH-NIDA

Grant: U01-DA050442-01

National Institutes of Health

Grant: 5U01DA050442-03

Using Implementation Interventions and Peer Recovery Support to Improve Opioid Treatment Outcomes in Community Supervision

NIDA NIH HHS

Grant: T32 DA016184

NIDA NIH HHS

Grant: U01 DA050442

FWCI

1.20

Citation Percentile

0.8%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://ascpjournal.biomedcentral.com/counter/pdf/10.1186/s13722-024-00528-9

publisherhttps://ascpjournal.biomedcentral.com/counter/pdf/10.1186/s13722-024-00528-9

publisherhttps://link.springer.com/content/pdf/10.1186/s13722-024-00528-9.pdf

publisherhttps://link.springer.com/article/10.1186/s13722-024-00528-9/fulltext.html

journalhttps://doi.org/10.1186/s13722-024-00528-9

Fields of Study

Opioid Use Disorder TreatmentSubstance Abuse Treatment and OutcomesHIV, Drug Use, Sexual Risk03 medical and health sciences0302 clinical medicine0305 other medical scienceHumansOpioid-Related DisordersPrisonersOpiate Substitution TreatmentFemaleInterviews as TopicMaleQualitative ResearchAdultStakeholder ParticipationNarcotic Antagonists

MeSH Terms

Stakeholder ParticipationAdultFemaleHumansInterviews as TopicMaleNarcotic AntagonistsOpioid-Related DisordersPrisonersQualitative ResearchOpiate Substitution Treatment

Keywords

Opioid use disorderAgency (philosophy)Thematic analysisReceiptNursingContext (archaeology)Public relationsPopulationMedicinePsychologyBusinessQualitative researchSociologyPolitical scienceOpioidEnvironmental healthProbationMaleAdultMedicine (General)ResearchPrisonersNarcotic AntagonistsOpioid-Related DisordersCriminal legalInterviews as TopicR5-920Social pathology. Social and public welfare. CriminologyStakeholder ParticipationOpiate Substitution TreatmentTreatment provisionHumansFemaleHV1-9960

Sustainable Development Goals

SDG 0: Good health and well-being